These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20565323)

  • 1. Predictors of reincarceration and disease progression among released HIV-infected inmates.
    Baillargeon J; Giordano TP; Harzke AJ; Spaulding AC; Wu ZH; Grady JJ; Baillargeon G; Paar DP
    AIDS Patient Care STDS; 2010 Jun; 24(6):389-94. PubMed ID: 20565323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.
    Springer SA; Pesanti E; Hodges J; Macura T; Doros G; Altice FL
    Clin Infect Dis; 2004 Jun; 38(12):1754-60. PubMed ID: 15227623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessing antiretroviral therapy following release from prison.
    Baillargeon J; Giordano TP; Rich JD; Wu ZH; Wells K; Pollock BH; Paar DP
    JAMA; 2009 Feb; 301(8):848-57. PubMed ID: 19244192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.
    Meyer JP; Cepeda J; Springer SA; Wu J; Trestman RL; Altice FL
    Lancet HIV; 2014 Nov; 1(2):e77-e84. PubMed ID: 25473651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrollment in outpatient care among newly released prison inmates with HIV infection.
    Baillargeon JG; Giordano TP; Harzke AJ; Baillargeon G; Rich JD; Paar DP
    Public Health Rep; 2010; 125 Suppl 1(Suppl 1):64-71. PubMed ID: 20408389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.
    Loeliger KB; Altice FL; Desai MM; Ciarleglio MM; Gallagher C; Meyer JP
    Lancet HIV; 2018 Feb; 5(2):e96-e106. PubMed ID: 29191440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
    Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of reincarceration among prisoners with co-occurring severe mental illness and substance use disorders.
    Baillargeon J; Penn JV; Knight K; Harzke AJ; Baillargeon G; Becker EA
    Adm Policy Ment Health; 2010 Jul; 37(4):367-74. PubMed ID: 19847638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing epidemiology of HIV in the criminal justice system.
    Baillargeon J; Pulvino JS; Leonardson JE; Linthicum LC; Williams B; Penn J; Williams RS; Baillargeon G; Murray OJ
    Int J STD AIDS; 2017 Nov; 28(13):1335-1340. PubMed ID: 28449629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
    Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
    Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Immunologic and Virologic Function in Reincarcerated Patients Living With HIV or AIDS.
    Badowski ME; Patel M
    J Correct Health Care; 2022 Jun; 28(3):203-206. PubMed ID: 35447035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail.
    Clements-Nolle K; Marx R; Pendo M; Loughran E; Estes M; Katz M
    Am J Public Health; 2008 Apr; 98(4):661-6. PubMed ID: 18309132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral outcomes in South African prisoners: a retrospective cohort analysis.
    Davies NE; Karstaedt AS
    PLoS One; 2012; 7(3):e33309. PubMed ID: 22470448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral prescribing patterns in the Texas prison system.
    Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
    Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jail inmates and HIV care: provision of antiretroviral therapy and Pneumocystis carinii pneumonia prophylaxis.
    White MC; Mehrotra A; Menendez E; Estes M; Goldenson J; Tulsky JP
    Int J STD AIDS; 2001 Jun; 12(6):380-5. PubMed ID: 11368819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail.
    Pai NP; Estes M; Moodie EE; Reingold AL; Tulsky JP
    PLoS One; 2009 Sep; 4(9):e7115. PubMed ID: 19771176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
    Jaén A; Esteve A; Miró JM; Tural C; Montoliu A; Ferrer E; Riera M; Segura F; Force L; Sued O; Vilaró J; Garcia I; Masabeu A; Altès J; Coltet B; Podzamczer D; Murillas J; Navarro G; Gatell JM; Casabona J;
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):212-20. PubMed ID: 18297762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
    Wohl DA; Golin CE; Knight K; Gould M; Carda-Auten J; Groves JS; Napravnik S; Cole SR; White BL; Fogel C; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM
    J Acquir Immune Defic Syndr; 2017 May; 75(1):81-90. PubMed ID: 28277487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.